Sign up for free insights newsletter
AR

Arjo AB (publ)

ARJO-BNasdaq Stockholm

Need professional-grade analysis? Visit stockanalysis.com

SEK 25.00
+1.21%
End of day
Market Cap

$6.92B

P/E Ratio

20.67

Employees

7,000

Dividend Yield

3.70%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-3.07-3.99-2.25-2.15-1.53-2.27
Calmar-27.42-6.70-2.63-1.73-1.00-4.04
Sharpe-4.83-3.80-1.99-1.82-1.17-2.10
Omega0.000.340.510.630.790.58
Martin-46.08-13.04-4.26-3.45-2.02-7.25
Ulcer1.695.1014.6613.6416.5912.89

Arjo AB (publ) (ARJO-B) Price Performance

Arjo AB (publ) (ARJO-B) trades on Nasdaq Stockholm in SEK. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at SEK25.00, up 1.21% from the previous close.

Over the past year, ARJO-B has traded between a low of SEK24.70 and a high of SEK36.87. The stock has lost 32.2% over this period. It is currently 32.2% below its 52-week high.

Arjo AB (publ) has a market capitalization of $6.92B, with a price-to-earnings ratio of 20.67 and a dividend yield of 3.70%.

About Arjo AB (publ)

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobility, architects and planners, and rehabilitation services, as well as equipment repair and maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.

Company Info

Exchange
Nasdaq Stockholm
Currency
SEK
Country
Sweden

Financial Metrics

Revenue (TTM)
$11.00B
EBITDA
$1.48B
Profit Margin
3.04%
EPS (TTM)
1.23
Book Value
27.38

Technical Indicators

52 Week High
SEK 37.41
52 Week Low
SEK 24.64
50 Day MA
SEK 28.19
200 Day MA
SEK 31.50
Beta
0.77

Valuation

Trailing P/E
20.67
Forward P/E
15.27
Price/Sales
0.63
Price/Book
0.94
Enterprise Value
$7.42B